{"chunk_id": "9789241505550_eng__chunk_541", "source": "9789241505550_eng", "text": "s translated into expected effects in terms of population prevalence reductions (i.e. \nrates of improvement in the population). Victora and colleagues ( 12) have discussed in detail the \ndifferences expected between efficacy rates and those from routine programmes. The Lancet \nseries reported simulations for coverages, giving the outputs as mortality, stunting and disability-\nadjusted life years ( 11). Rates are used as the outcome for effectiveness, and effect sizes given \nas ppt/year. \n1 Usual"}